Results from the study will be used in the submission to the FDA to support clearance that the company currently anticipates to receive in the middle of 2023. "This study was a multi-center, ...
limited image quality at the retina, which will enable the investigation of the psychophysical limits of human vision. We will later show some preliminary results from testing human subjects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results